238 related articles for article (PubMed ID: 30455249)
1. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.
Helzer KT; Szatkowski Ozers M; Meyer MB; Benkusky NA; Solodin N; Reese RM; Warren CL; Pike JW; Alarid ET
Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30455249
[TBL] [Abstract][Full Text] [Related]
2. GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.
Reese RM; Helzer KT; Allen KO; Zheng C; Solodin N; Alarid ET
Mol Cell Biol; 2022 Oct; 42(10):e0019122. PubMed ID: 36036613
[TBL] [Abstract][Full Text] [Related]
3. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
4. Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation.
Li W; Hu Y; Oh S; Ma Q; Merkurjev D; Song X; Zhou X; Liu Z; Tanasa B; He X; Chen AY; Ohgi K; Zhang J; Liu W; Rosenfeld MG
Mol Cell; 2015 Jul; 59(2):188-202. PubMed ID: 26166704
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.
Stender JD; Kim K; Charn TH; Komm B; Chang KC; Kraus WL; Benner C; Glass CK; Katzenellenbogen BS
Mol Cell Biol; 2010 Aug; 30(16):3943-55. PubMed ID: 20547749
[TBL] [Abstract][Full Text] [Related]
6. ELF5 modulates the estrogen receptor cistrome in breast cancer.
Piggin CL; Roden DL; Law AMK; Molloy MP; Krisp C; Swarbrick A; Naylor MJ; Kalyuga M; Kaplan W; Oakes SR; Gallego-Ortega D; Clark SJ; Carroll JS; Bartonicek N; Ormandy CJ
PLoS Genet; 2020 Jan; 16(1):e1008531. PubMed ID: 31895944
[TBL] [Abstract][Full Text] [Related]
7. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription.
Nagarajan S; Benito E; Fischer A; Johnsen SA
Oncotarget; 2015 Mar; 6(9):7305-17. PubMed ID: 25788266
[TBL] [Abstract][Full Text] [Related]
8. VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.
Holding AN; Giorgi FM; Donnelly A; Cullen AE; Nagarajan S; Selth LA; Markowetz F
Genome Biol; 2019 May; 20(1):91. PubMed ID: 31084623
[TBL] [Abstract][Full Text] [Related]
9. Estrogen regulation of trefoil factor 1 expression by estrogen receptor alpha and Sp proteins.
Sun JM; Spencer VA; Li L; Yu Chen H; Yu J; Davie JR
Exp Cell Res; 2005 Jan; 302(1):96-107. PubMed ID: 15541729
[TBL] [Abstract][Full Text] [Related]
10. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.
Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ
Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947
[TBL] [Abstract][Full Text] [Related]
11. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
12. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes.
Guertin MJ; Zhang X; Coonrod SA; Hager GL
Mol Endocrinol; 2014 Sep; 28(9):1522-33. PubMed ID: 25051172
[TBL] [Abstract][Full Text] [Related]
13. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
14. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
15. Integrative model of genomic factors for determining binding site selection by estrogen receptor-α.
Joseph R; Orlov YL; Huss M; Sun W; Kong SL; Ukil L; Pan YF; Li G; Lim M; Thomsen JS; Ruan Y; Clarke ND; Prabhakar S; Cheung E; Liu ET
Mol Syst Biol; 2010 Dec; 6():456. PubMed ID: 21179027
[TBL] [Abstract][Full Text] [Related]
16. TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.
Broome R; Chernukhin I; Jamieson S; Kishore K; Papachristou EK; Mao SQ; Tejedo CG; Mahtey A; Theodorou V; Groen AJ; D'Santos C; Balasubramanian S; Farcas AM; Siersbæk R; Carroll JS
Cell Rep; 2021 Feb; 34(8):108776. PubMed ID: 33626359
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor signaling is reprogrammed during breast tumorigenesis.
Chi D; Singhal H; Li L; Xiao T; Liu W; Pun M; Jeselsohn R; He H; Lim E; Vadhi R; Rao P; Long H; Garber J; Brown M
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11437-11443. PubMed ID: 31110002
[TBL] [Abstract][Full Text] [Related]
18. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
[TBL] [Abstract][Full Text] [Related]
19. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
20. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]